When considering the forces claiming lives across the Middle East and North Africa (MENA), minds inevitably turn to warfare and terrorism. Yet the region’s most prolific killer does not carry a weapon. Its methods are salt, sugar, and sitting.
The numbers are staggering. Cardiovascular disease kills approximately 1.4 million people in the region every year; diabetes adds 796,000 deaths to the toll. These so-called non-communicable diseases, along with others like stroke and mental illness, account for 74 percent of regional mortality.
This reframing opens a rare opportunity for global health diplomacy: regional and international cooperation around the surveillance, prevention, and management of cardiometabolic diseases should be pursued with the same diligence that one would apply to a biologically infectious disease outbreak. One can look to the President’s Emergency Plan for AIDS Relief (PEPFAR), which by some estimates saved 25 million lives, as a model for what coordinated political will can achieve. Strategic investments in disease prevention, continuous monitoring, weight-loss medications, meal modification, smarter city planning, and increased physical activity are simple, relatively inexpensive ways to move the needle for millions of people who struggle with cardiometabolic diseases.
SIGN UP FOR THIS WEEK IN THE MIDEAST NEWSLETTER
If this crisis goes unaddressed, the consequences will be devastating. Diabetes alone is projected to cost the region $1.5 trillion annually by 2050. But this economic toll is only the beginning; the cardiometabolic crisis has also become a self-reinforcing driver of regional instability.
The lack of preventative health care systems, adequate educational programming, monitoring and surveillance infrastructure, appropriate medication and clinical care, plays out most painfully at the household level. Avoiding cardiometabolic diseases requires inexpensive changes to dietary and lifestyle behaviors. By contrast, managing cardiometabolic diseases requires costly lifelong medication and monitoring by patients, families, and specialists. In a region where nearly 38 percent of diabetic individuals remain undiagnosed, the physical and financial reckoning often arrives too late to prevent serious, irreversible damage. Research consistently shows that households dealing with noncommunicable diseases face a significantly elevated risk of catastrophic health expenditures.
There is, nonetheless, genuine cause for optimism. This is a preventable catastrophe and a natural space for robust regional and international cooperation. The tools already exist and are growing more powerful as artificial intelligence disrupts the fields of medicine and public health. Economic analysis shows that scaling up World Health Organization–recommended noncommunicable disease interventions—reducing smoking, alcohol consumption, unhealthy diets, and sedentary lifestyles—across GCC countries would return $4.90 for every $1 invested, averting roughly 290,000 premature deaths.
What remains missing is the political will, regionally and internationally, to treat cardiometabolic diseases with the same urgency applied to infectious outbreaks and national security threats. The international community must draw on the lessons of PEPFAR and mobilize a global coalition of governments, pharmaceutical companies, medical device manufacturers, payers, providers, and most importantly the citizens of these countries.
This article is supported by Roche. The author is solely responsible for the article’s analysis and recommendations.
Image: A nurse checks the blood pressure of a woman at a health clinic in Jinwar, an all-women village, in Al-Darbasiyah town that is controlled by Kurdish-led Syrian Democratic Forces, northeastern Syria, March 11, 2023. REUTERS/Orhan Qereman
